|
May 26, 2010
Health Enhancement Products Announces Details of Its June 8th Scientific Panel Presentation |
May 11, 2010
Health Enhancement Products Schedules Press Event June 8 to Present Breakthroughs in Its Cholesterol Management Research |
April 26, 2010
Health Enhancement Products Secures Funding Enabling the Company to Begin Phase O Clinical Trials |
April 21, 2010
Health Enhancement Products Names Denis M. Callewaert, Ph.D. to Its New Chief Science Officer Position |
April 13, 2010
Professor of Molecular Toxicology at Penn State University, Jack Vanden Heuvel PhD, to Join Health Enhancement Products Scientific Advisory Boardt |
March 9, 2010
Wayne State University Researchers Discover Potentially New Means to Regulate Bad Cholesterol and Raise HDL (Good Cholesterol) With Bioactive Molecules Derived From ProAlgaZyme(TM) -- a Proprietary Algal Extract
|
July 20, 2010
Health Enhancement Products Expands Scientific Advisory Board
Dr. Donald Armstrong, Noted Expert in Oxidative Stress and Inflammation, Joins as Science Advisor
|
Health Enhancement Products is a member of these organizations
|
|
| |
|
|
| May 26, 2010 |
Health Enhancement Products Announces Details of Its June 8th Scientific Panel Presentation
|
| May 11, 2010 |
Health Enhancement Products Schedules Press Event June 8 to Present Breakthroughs in Its Cholesterol Management Research
|
| April 26, 2010 |
Health Enhancement Products Secures Funding Enabling the Company to Begin Phase O Clinical Trials
|
| April 21, 2010 |
Health Enhancement Products Names Denis M. Callewaert, Ph.D. to Its New Chief Science Officer Position |
| April 13, 2010 |
Professor of Molecular Toxicology at Penn State University, Jack Vanden Heuvel PhD, to Join Health Enhancement Products Scientific Advisory Boardt |
| March 9, 2010 |
Wayne State University Researchers Discover Potentially New Means to Regulate Bad Cholesterol and Raise HDL (Good Cholesterol) With Bioactive Molecules Derived From ProAlgaZyme(TM) -- a Proprietary Algal Extract |
| Feb 22, 2010 |
Health Enhancement Products, Inc. Proceeds With Patent Filings for Newly Isolated and Previously Undiscovered Compounds Regulating Cholesterol Metabolism |
| Feb 10, 2010 |
Health Enhancement Products Retains Intellectual Property Law Experts Kohn & Associates pllc |
| Feb 8, 2010 |
Neurosurgeon-Scientist Eric C. Holland, MD, PhD to Join Health Enhancement Products Scientific Advisory Board |
| Dec 1, 2009 |
Health Enhancement Products Begins New Tests to Probe Potential Effects of ProAlgaZyme(R) on in Vitro Growth of Human Pancreatic Cancer Cells |
| Nov 30, 2009 |
Health Enhancement Products to Present at the 2nd Annual LD MICRO Conference |
| Nov 3, 2009 |
Prominent Research Scientist at Wayne State University School of Medicine Announces Positive Results for Anti-Inflammatory Properties of Health Enhancement Products, Inc. Proalgazyme Compound |
| Oct 6, 2009 |
Wayne State University Announces Positive Lipid Oxidation Test Results for Potential Management of Oxidative Stress Using Health Enhancement Products' ProAlgaZyme Filtrates |
| Oct 2, 2009 |
Health Enhancement Products Reacquires ProAlgaZyme Distribution and Marketing Rights |
| Sept 8, 2009 |
Health Enhancement Products
names Peter Vitulli
as interim CEO |
| August 25, 2009 |
Wayne State University Preliminary Study On Health Enhancement Products, PAZ, Indicates Encouraging Results in Inflammation When Managing Cholesterol; Study is Expanded |
| July 20, 2009 |
Health Enhancement Products Expands Scientific Advisory Board |
| July 15, 2009 |
Health Enhancement Products Announces Positive Preliminary Analysis of Wayne State University Study |
| July 1, 2009 |
Health Enhancement Products Anounces
Expansion
Of It's Primary Facilty. |
| Dec 13, 2007 |
Health Enhancement Products signs contract with Specialty Nutrition Group, Inc for Re-Branding and Product Marketing of ProAlgaZyme. |
| Nov 14, 2007 |
HEALTH ENHANCEMENT PRODUCTS INC Files SEC form 10QSB, Quarterly Report |
| Nov 14, 2007 |
Health Enhancement Products Announced the Long Awaited Discovery of a Class of "Orally Active Agents" in Its Primary Product, ProAlgaZyme |
| Nov 6, 2007 |
Health Enhancement Products Reports Results in the Second Testing of the ProAlgaZyme Clinical Lot Used in the Suspended Clinical Trial |
| Oct 25, 2007 |
Health Enhancement Products Reports Results in Testing of the ProAlgaZyme Clinical Lot Used in the Suspended Clinical Trial |
| Sept 24, 2007 |
Health Enhancement Products Announces the Signing of a Broker Agreement With Natural Brokers, Inc. |
| Sept 10, 2007 |
Health Enhancement Products Announces Peer-Reviewed Publication of a Clinical Study Involving Metabolic Syndrome and Markers of Cardiovascular Health
|
| Sept 7, 2007 |
Health Enhancement Products, Inc. and HEPI Pharmaceuticals, Inc. Announce Resignation of CEO |
| Sept 1, 2007 |
Health Enhancement Products, Inc. Announces Teleconference to Discuss Clinical Trial Stoppage |
| Aug 31, 2007 |
HEPI Pharmaceuticals, Inc. Stops Trial of ProAlgaZyme Due to Concerns Raised by Inconsistent Result |
| July 12, 2007 |
Health Enhancement Products Announces Dr. Robert Cohen to Join Scientific Advisory Board |
| June 27, 2007 |
HEPI Pharmaceuticals, Inc. Files Patent Application to Protect Potential Active Components of ProAlgaZyme(R) |
| June 14, 2007 |
Health Enhancement Products Announces Exhibition Booth at 70th Annual Natural Products Trade Show and Convention in Las Vegas on July 20-2 |
| March 22, 2007 |
HEPI Pharmaceuticals, Inc. Announces Initiation of U.S.-Based Clinical Trial of ProAlgaZyme to Corroborate Previous Clinical Trial Results in Metabolic Syndrome |
| Feb 21, 2007 |
Health Enhancement Products, Inc. to Distribute Shares of Pharmaceutical Subsidiary to Shareholders |
| Jan 25, 2007 |
Health Enhancement Products to Create Pharmaceutical Division to Pursue Potential Pharmaceutical Applications for ProAlgaZyme |
| Jan 19, 2007 |
Health Enhancement Products Announces Final Results of Clinical Trials of ProAlgaZyme in Metabolic Syndrome and HIV Patients |
| Dec 4, 2006 |
Health Enhancement Products Finalizes Settlement With the SEC and Undergoes Management Change |
| Thurs, |
Health Enhancement Products Releases Preliminary HIV and Metabolic Syndrome Clinical Study Results
|
| Sept 28, 2006 |
Health Enhancement Products, Inc. to Update Public Regarding Results of HIV and Metabolic Syndrome Clinical Trials, and Other Current Events
|
| May 22, 2006 |
Health Enhancement Products Announces Commencement of HIV And CRP Clinical Trials in Cameroon |
| May 4, 2006 |
Health Enhancement Products Inc. Files International Patent Application to Protect Worldwide Rights to ProAlgaZyme |
| May 1, 2006 |
Health Enhancement Products Receives Approval to Commence HIV and CRP Clinical Trial in Cameroon |
| April 3, 2006 |
Health Enhancement Products Appoints Dr. Mark Anderson to Scientific Advisory Board
|
| Dec 6, 2005 |
Health Enhancement Products Announces Appointment of Ex-White House Chief of Staff, Hamilton Jordan, to Its Scientific Advisory Board |
| Nov 17, 2005 |
Health Enhancement Products Announces Marketing and Distribution Agreement with Suarez Corporation Industries
|
| Mon, |
Health Enhancement Products Announces Laboratory Analysis Indicates PAZ Contains a Substance Associated with Appetite Suppression |
| Sept 22, 2005 |
Health Enhancement Products Files for Patent Covering ProAlgaZyme Product |
| Sept
23, 2004 |
Health
Enhancement Products Announces Two Studies
That Show ProAlgaZyme(TM) Reduces Edema (Swelling)
In Lab Animals |
| July
15,
2004 |
Health
Enhancement Products to Start Clinical Trials
on Its Primary Product, ProAlgaZyme |
| April
29, 2004 |
Health
Enhancement Products Files for Patent Covering
ProAlgaZyme Product |
| March
30, 2004 |
Health
Enhancement Products Announces Official Launch
of ProAlgaZyme |
| Feb
13, 2004 |
Blood
Tests Suggest ProAlgaZyme May
Support Compromised Immune Systems |
| Dec
18, 2003 |
Health
Enhancement Products Acquires ReplenTish Product
Line and Related Trademarks
|
|
|
|
